Patents by Inventor Marc Lippman

Marc Lippman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rac inhibitors
    Patent number: 10472352
    Abstract: The present invention relates to compounds that act as pan-Rac inhibitors, compositions including the compounds, and methods of using the compounds. In particular, the compounds are useful for treating certain cancers such as breast cancer.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: November 12, 2019
    Assignee: GENEYUS LLC
    Inventors: Marc Lippman, Erik Goka, Shawn D. Johnstone, Malken Bayrakdarian, William Brown, Jeffrey S. Albert
  • RAC INHIBITORS
    Publication number: 20190031647
    Abstract: The present invention relates to compounds that act as pan-Rac inhibitors, compositions including the compounds, and methods of using the compounds. In particular, the compounds are useful for treating certain cancers such as breast cancer.
    Type: Application
    Filed: July 25, 2018
    Publication date: January 31, 2019
    Applicant: Geneyus LLC
    Inventors: Marc LIPPMAN, Erik GOKA, Shawn D. JOHNSTONE, Malken BAYRAKDARIAN, William BROWN, Jeffrey S. ALBERT
  • Oligonucleotide based therapeutics
    Publication number: 20060166920
    Abstract: The present invention relates to compositions comprising dsRNA. In particular, the present invention provides dsRNA comprising nucleotide sequence that is selectively complementary to bcl-xL mRNA sequence and that is not selectively complementary to bcl-xS mRNA sequence, recombinant nucleic acid comprising a vector and nucleic acid sequence for expressing bcl-xL dsRNA, pharmaceutical compositions comprising bcl-xL dsRNA, kits comprising such compositions, and methods of using the same in research, therapeutic, diagnostic and/or drug screening applications.
    Type: Application
    Filed: December 27, 2005
    Publication date: July 27, 2006
    Applicant: Regents of the University of Michigan
    Inventors: Liang Xu, Marc Lippman, Meilan Liu
  • VEGI, an inhibitor of angiogenesis and tumor growth
    Publication number: 20050214305
    Abstract: The present invention relates to a vascular endothelial cell inhibitor, VEGI, capable of inhibiting angiogenesis in cellular models and tumourigenesis in animal models, and methods of use.
    Type: Application
    Filed: December 14, 2004
    Publication date: September 29, 2005
    Applicants: Human Genome Sciences, Inc., Georgetown University Medical Center
    Inventors: Lu-Yuan Li, Yifan Zhai, Guo-Liang Yu, Jian Ni, Marc Lippman, Craig Rosen